Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Locke

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|May 19, 2007
Validation of the Mayo Dysphagia QuestionnaireA B M Grudell, J A Alexander, F B Enders, et al.
Gastroenterology|December 13, 2000
Epidemiology and natural history of primary biliary cirrhosis in a US communityW R Kim, K D Lindor, G R Locke, et al.
Neurogastroenterology and Motility|September 5, 2013
Novel partial 5HT3 agonist pumosetrag reduces acid reflux events in uninvestigated GERD patients after a standard refluxogenic meal: a randomized, double-blind, placebo-controlled pharmacodynamic studyR S Choung, G R Locke, D D Francis, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|May 19, 2007
Validation of the Mayo Dysphagia QuestionnaireA B M Grudell, J A Alexander, F B Enders, et al.
Gastroenterology|December 13, 2000
Epidemiology and natural history of primary biliary cirrhosis in a US communityW R Kim, K D Lindor, G R Locke, et al.
Neurogastroenterology and Motility|September 5, 2013
Novel partial 5HT3 agonist pumosetrag reduces acid reflux events in uninvestigated GERD patients after a standard refluxogenic meal: a randomized, double-blind, placebo-controlled pharmacodynamic studyR S Choung, G R Locke, D D Francis, et al.
Pageof 9